A randomized, double-blind, placebo-controlled phase 3 study of the relative efficacy and tolerability of tapentadol IR and oxycodone IR for acute pain

By Daniels Stephen   Casson Ed   Stegmann Jens-Ulrich   Oh Charles   Okamoto Akiko   Rauschkolb Christine   Upmalis David  

Current Medical Research and Opinion, Vol. 25, Iss. 6, 2009-06 ,pp. : 1551-1561

Informa Healthcare

Access to resources Recommend Favorite

A randomized, double-blind, phase III study comparing multiple doses of tapentadol IR, oxycodone IR, and placebo for postoperative (bunionectomy) pain*

By Daniels Stephen E.   Upmalis David   Okamoto Akiko   Lange Claudia   Häeussler Jüergen  

Current Medical Research and Opinion, Vol. 25, Iss. 3, 2009-03 ,pp. : 765-776

Informa Healthcare

Access to resources Recommend Favorite

Intravenous pamidronate for pain relief in recent osteoporotic vertebral compression fracture: a randomized double-blind controlled study

By Armingeat T.   Brondino R.   Pham T.   Legré V.   Lafforgue P.  

Osteoporosis International, Vol. 17, Iss. 11, 2006-11 ,pp. : 1659-1665

Springer Publishing Company

Access to resources Recommend Favorite

Effectiveness and Safety of Tapentadol Prolonged Release (PR) Versus a Combination of Tapentadol PR and Pregabalin for the Management of Severe, Chronic Low Back Pain With a Neuropathic Component: A Randomized, Double‐blind, Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 455-470

John Wiley & Sons Inc

Access to resources Recommend Favorite

Effectiveness and Tolerability of a Moderate Dose of Tapentadol Prolonged Release for Managing Severe, Chronic Low Back Pain with a Neuropathic Component: An Open‐label Continuation Arm of a Randomized Phase 3b Study

By  

PAIN PRACTICE, Vol. 15, Iss. 5, 2015-06 ,pp. : 471-486

John Wiley & Sons Inc

Access to resources Recommend Favorite